Caselli A, Spallone V, Marfia G A, Battista C, Pachatz C, Veves A, Uccioli L
Department of Internal Medicine, University of Tor Vergata, Viale Oxford, 81 00133 Rome, Italy.
J Neurol Neurosurg Psychiatry. 2006 Aug;77(8):927-32. doi: 10.1136/jnnp.2005.069609. Epub 2006 Apr 19.
To validate nerve-axon reflex-related vasodilatation as an objective method to evaluate C-nociceptive fibre function by comparing it with the standard diagnostic criteria.
Neuropathy was evaluated in 41 patients with diabetes (26 men and 15 women) without peripheral vascular disease by assessing the Neuropathy Symptom Score, the Neuropathy Disability Score (NDS), the vibration perception threshold (VPT), the heat detection threshold (HDT), nerve conduction parameters and standard cardiovascular tests. The neurovascular response to 1% acetylcholine (Ach) iontophoresis was measured at the forearm and at both feet by laser flowmetry. An age-matched and sex-matched control group of 10 healthy people was also included.
Significant correlations were observed between the neurovascular response at the foot and HDT (r(s) = -0.658; p<0.0001), NDS (r(s) = -0.665; p<0.0001), VPT (r(s) = -0.548; p = 0.0005), tibial nerve conduction velocity (r(s) = 0.631; p = 0.0002), sural nerve amplitude (r(s) = 0.581; p = 0.0002) and autonomic function tests. According to the NDS, in patients with diabetes who had mild, moderate or severe neuropathy, a significantly lower neurovascular response was seen at the foot than in patients without neuropathy and controls. A neurovascular response <50% was found to be highly sensitive (90%), with a good specificity (74%), in identifying patients with diabetic neuropathy.
Small-fibre dysfunction can be diagnosed reliably with neurovascular response assessment. This response is already reduced in the early stages of peripheral neuropathy, supporting the hypothesis that small-fibre impairment is an early event in the natural history of diabetic neuropathy.
通过与标准诊断标准进行比较,验证神经轴突反射相关血管舒张作为评估C类伤害性纤维功能的客观方法。
对41例无外周血管疾病的糖尿病患者(26例男性和15例女性)进行神经病变评估,评估内容包括神经病变症状评分、神经病变残疾评分(NDS)、振动觉阈值(VPT)、热觉检测阈值(HDT)、神经传导参数和标准心血管测试。通过激光血流仪在前臂和双足测量对1%乙酰胆碱(Ach)离子导入的神经血管反应。还纳入了10名年龄和性别匹配的健康人作为对照组。
足部神经血管反应与HDT(r(s)= -0.658;p<0.0001)、NDS(r(s)= -0.665;p<0.0001)、VPT(r(s)= -0.548;p = 0.0005)、胫神经传导速度(r(s)= 0.631;p = 0.0002)、腓肠神经波幅(r(s)= 0.581;p = 0.0002)及自主神经功能测试之间存在显著相关性。根据NDS,在患有轻度、中度或重度神经病变的糖尿病患者中,足部的神经血管反应明显低于无神经病变的患者和对照组。发现神经血管反应<50%在识别糖尿病神经病变患者时具有高度敏感性(90%)和良好的特异性(74%)。
通过神经血管反应评估可可靠诊断小纤维功能障碍。这种反应在周围神经病变早期就已降低,支持了小纤维损伤是糖尿病神经病变自然病程中早期事件的假说。